Skip to main content

Publication, Part of

Non-Diabetic Hyperglycaemia, 2021-22, Diabetes Prevention Programme, Detailed Analysis Report

Changes to NDA reporting

NHS England are currently reviewing the routine production of NDA State of the Nation reports. Please note that data will still be released via dashboards and standalone data files whilst this review is being conducted.

To help inform this review we would be grateful if users can provide feedback on their use of the State of the Nation reports using the feedback survey available in the 'Related links' section of this page.

3 June 2024 00:00 AM

Page contents

Diabetes Prevention Programme

The NHS Diabetes Prevention Programme (DPP) is a lifestyle change programme offered to people who are identified with a high risk of developing type 2 diabetes in order to reduce that risk.

People are eligible1 for referral to the DPP if they have had a glycaemic test result in the appropriate range (HbA1c: 42 – 47 mmol/mol; fasting plasma glucose: 5.5 – 6.9 mmol/L) within the last 12 months (this was extended to 24 months during the COVID-19 pandemic, at which time people were also able to directly self refer into the programme). Not everyone with an NDH diagnosis will be eligible to be referred to the DPP, either because they do not have a recent glycaemic test result in the appropriate range, or because the programme is otherwise not appropriate.

1,083,260 people with a current GP record of NDH have been offered DPP, according to their GP record; and of these 753,245 did not decline the DPP referral offer.

Are people in the DPP recorded with non-diabetic hyperglycaemia?

Table 6: People with a DPP referral1, by GP recording of diabetes or non-diabetic hyperglycaemia, 2021-22, England

 

Diagnosis in GP record Number Per cent
Total 806,450  
- Referrals from GP / healthcare 783,415  
- - NDH diagnosis 531,320 67.8%
- - Diabetes diagnosis 15,515 2.0%
- - No diagnosis 236,575 30.2%
- Self referrals 23,035  

 

Footnotes:

  1. People included had a referral to the Diabetes Prevention Programme recorded by a DPP provider, were recorded with a known valid NHS number, and were registered at a GP practice that participated in NDA 2021-22. This does not include people who participated in the DPP and opted out of onward data sharing,

Figure 4: DPP referrals1 without a GP recorded diagnosis, by ICB2, GP-recorded non-diabetic hyperglycaemia (NDH) or diabetes, provider DPP referral, 2021-22, England

The level of DPP referrals missing an NDH or diabetes diagnosis varies across England, with more than half of referrals in some ICBs having no recorded GP diagnosis.

 

Footnotes:

  1. People included had a referral to the Diabetes Prevention Programme recorded by a DPP provider, from a GP / healthcare setting, were recorded with a known valid NHS number, and were registered at a GP practice that participated in NDA 2021-22. This does not include people who participated in the DPP and opted out of onward data sharing,
  2. ICBs were included where at least 100 people had been referred to the Diabetes Prevention Programme (all 42 ICBs).
  3. Diabetes diagnoses are considered here because of the possibility of someone with NDH progressing to diabetes before referral.

Recommendation 3

ICBs should ensure that eligible people with NDH are offered the NHS Diabetes Prevention Programme if clinically appropriate, with particular focus on supporting people with greater risk of progression to diabetes (i.e. those from the most deprived quintile, aged under 65, of Black or Asian ethnicity, and/or those living with obesity).



Last edited: 3 June 2024 10:21 am